Abenavoli L - Search Results

1

A pathogenetic link between non-alcoholic fatty liver disease and celiac disease.

Abenavoli L, Milic N, De Lorenzo A, Luzza F. Abenavoli L, et al. Endocrine. 2013 Feb;43(1):65-7. doi: 10.1007/s12020-012-9731-y. Epub 2012 Jun 28. Endocrine. 2013. PMID: 22740094

2

Role of interleukin-15 receptor alpha polymorphisms in normal weight obese syndrome.

Di Renzo L, Gloria-Bottini F, Saccucci P, Bigioni M, Abenavoli L, Gasbarrini G, De Lorenzo A. Di Renzo L, et al. Among authors: abenavoli l. Int J Immunopathol Pharmacol. 2009 Jan-Mar;22(1):105-13. doi: 10.1177/039463200902200112. Int J Immunopathol Pharmacol. 2009. PMID: 19309557 Free article.

3

Celiac disease: from gluten to skin.

Abenavoli L, Proietti I, Zaccone V, Gasbarrini G, Addolorato G. Abenavoli L, et al. Expert Rev Clin Immunol. 2009 Nov;5(6):789-800. doi: 10.1586/eci.09.46. Expert Rev Clin Immunol. 2009. PMID: 20477697

4

Milk thistle in liver diseases: past, present, future.

Abenavoli L, Capasso R, Milic N, Capasso F. Abenavoli L, et al. Phytother Res. 2010 Oct;24(10):1423-32. doi: 10.1002/ptr.3207. Phytother Res. 2010. PMID: 20564545 Review.

5

Short-term therapy with celecoxib and lansoprazole modulates Th1/ Th2 immune response in human gastric mucosa.

Larussa T, Suraci E, Leone I, Nazionale I, Abenavoli L, Galasso O, Amorosi A, Imeneo M, Luzza F. Larussa T, et al. Among authors: abenavoli l. Helicobacter. 2010 Oct;15(5):449-59. doi: 10.1111/j.1523-5378.2010.00796.x. Helicobacter. 2010. PMID: 21083751

6

Transient elastography in non-alcoholic fatty liver disease.

Abenavoli L, Beaugrand M. Abenavoli L, et al. Ann Hepatol. 2012 Mar-Apr;11(2):172-8. Ann Hepatol. 2012. PMID: 22345333 Free article. Review.

7

High prevalence of polymorphism and low activity of thiopurine methyltransferase in patients with inflammatory bowel disease.

Larussa T, Suraci E, Lentini M, Nazionale I, Gallo L, Abenavoli L, Imeneo M, Costanzo FS, Cuda G, Luzza F. Larussa T, et al. Among authors: abenavoli l. Eur J Intern Med. 2012 Apr;23(3):273-7. doi: 10.1016/j.ejim.2011.12.002. Epub 2012 Jan 5. Eur J Intern Med. 2012. PMID: 22385887

8

[Drug-induced liver injury].

Abenavoli L, Libri E, Bosco D, Gallo D, Luzza F. Abenavoli L, et al. Recenti Prog Med. 2012 Feb;103(2):79-84. doi: 10.1701/1045.11392. Recenti Prog Med. 2012. PMID: 22430754 Review. Italian.

9

Anti-oxidant therapy in non-alcoholic fatty liver disease: the role of silymarin.

Abenavoli L, Milic N, Capasso F. Abenavoli L, et al. Endocrine. 2012 Dec;42(3):754-5. doi: 10.1007/s12020-012-9677-0. Endocrine. 2012. PMID: 22527892 No abstract available.

10

No evidence of circulating autoantibodies against osteoprotegerin in patients with celiac disease.

Larussa T, Suraci E, Nazionale I, Leone I, Montalcini T, Abenavoli L, Imeneo M, Pujia A, Luzza F. Larussa T, et al. Among authors: abenavoli l. World J Gastroenterol. 2012 Apr 14;18(14):1622-7. doi: 10.3748/wjg.v18.i14.1622. World J Gastroenterol. 2012. PMID: 22529691 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

354 results

Search Page

Filters